This page is part of the Single Institutional Review Board (sIRB) Implementation Guide (v0.1.0: STU 1 Ballot 1) based on FHIR R4. . For a full list of available versions, see the Directory of published versions
{
"resourceType" : "ResearchStudy",
"id" : "ResearchStudy2858",
"meta" : {
"versionId" : "2",
"lastUpdated" : "2021-07-28T19:08:33.805+00:00",
"source" : "#zj1czTsuUAVvoEBr"
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>identifier</b>: The Questionnaire Response ID for the associated Initiate a Study FHIR Questionnaire Response: QRID-2857 (USUAL), IRB Study Protocol Number assigned by the sIRB's external research study database: SUMC-1234567 (USUAL)</p><p><b>title</b>: Double blind, placebo-controlled trial of a new class of arthritis medication</p><p><b>protocol</b>: <a name=\"plan_definition-2857\"> </a></p><blockquote><p><b>identifier</b>: id: SUMC-1234567 (USUAL)</p><p><b>name</b>: PlanDef2857</p><p><b>status</b>: draft</p></blockquote><p><b>status</b>: in-review</p><p><b>category</b>: <span title=\"Codes: {http://ncimeta.nci.nih.gov C98388}\">Interventional Study</span></p><p><b>keyword</b>: <span title=\"Codes: {https://www.examplestudymanagementdb.org NIH-2021-123456}\">NIH-2021-123456</span></p><p><b>principalInvestigator</b>: <a name=\"practitioner-2857\"> </a></p><blockquote><p><b>name</b>: John Doe, IV, MD(OFFICIAL)</p></blockquote></div>"
},
"contained" : [
{
"resourceType" : "PlanDefinition",
"id" : "plan_definition-2857",
"identifier" : [
{
"use" : "usual",
"system" : "https://www.examplestudymanagementdb.org",
"value" : "SUMC-1234567"
}
],
"name" : "PlanDef2857",
"status" : "draft"
},
{
"resourceType" : "Practitioner",
"id" : "practitioner-2857",
"name" : [
{
"use" : "official",
"text" : "John Doe, IV, MD",
"family" : "Doe",
"given" : [
"John"
],
"suffix" : [
"IV",
"MD"
]
}
]
}
],
"identifier" : [
{
"use" : "usual",
"type" : {
"text" : "The Questionnaire Response ID for the associated Initiate a Study FHIR Questionnaire Response"
},
"system" : "https://www.example-fhir-server.com/hapi-fhir-jpaserver/fhir/QuestionnaireResponse",
"value" : "QRID-2857"
},
{
"use" : "usual",
"type" : {
"text" : "IRB Study Protocol Number assigned by the sIRB's external research study database"
},
"value" : "SUMC-1234567",
"assigner" : {
"display" : "Sample University Medical Center(SUMC)"
}
}
],
"title" : "Double blind, placebo-controlled trial of a new class of arthritis medication",
"protocol" : [
{
"reference" : "#plan_definition-2857"
}
],
"status" : "in-review",
"category" : [
{
"coding" : [
{
"system" : "http://ncimeta.nci.nih.gov",
"code" : "C98388",
"display" : "Interventional Study"
}
]
}
],
"keyword" : [
{
"coding" : [
{
"system" : "https://www.examplestudymanagementdb.org",
"code" : "NIH-2021-123456"
}
],
"text" : "NIH-2021-123456"
}
],
"principalInvestigator" : {
"reference" : "#practitioner-2857"
}
}